Clinical trial
Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasms
NCT06169163 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasms
- Lead sponsor
- Imperial College London
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 1, 2023
- Completion date
- December 31, 2026
- Enrollment
- 518 (estimated)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
oesophageal cancer, oesophageal squamous cell carcinoma